We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

315 hedge funds and large institutions have $1.99B invested in Amneal Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 79 funds opening new positions, 115 increasing their positions, 78 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 36

47% more repeat investments, than reductions

Existing positions increased: 115 | Existing positions reduced: 78

14% more funds holding

Funds holding: 277 → 315 (+38)

2% more capital invested

Capital invested by funds: $1.95B → $1.99B (+$39.9M)

0.95% more ownership

Funds ownership: 49.17% → 50.12% (+0.95%)

0% more funds holding in top 10

Funds holding in top 10: 6 → 6 (0)

56% less call options, than puts

Call options by funds: $635K | Put options by funds: $1.44M

Holders
315
Holders Change
+38
Holders Change %
+13.72%
% of All Funds
3.88%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
79
Increased
115
Reduced
78
Closed
36
Calls
$635K
Puts
$1.44M
Net Calls
-$803K
Net Calls Change
-$6.82M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$137M
2
State Street
State Street
Massachusetts
+$36M
3
Invesco
Invesco
Georgia
+$19.3M
4
Allspring Global Investments
Allspring Global Investments
North Carolina
+$14.4M
5
Principal Financial Group
Principal Financial Group
Iowa
+$11M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$75.2M
2
Millennium Management
Millennium Management
New York
-$40.2M
3
RCMNY
Rubric Capital Management (New York)
New York
-$17.4M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$17.1M
5
JG
Jain Global
New York
-$13.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCP
176
Perbak Capital Partners
United Kingdom
$362K +$391K +29,122 New
Pictet Asset Management
177
Pictet Asset Management
Switzerland
$356K – – –
Man Group
178
Man Group
United Kingdom
$352K -$463K -34,468 -55%
Cetera Investment Advisers
179
Cetera Investment Advisers
Illinois
$347K +$86.4K +6,437 +30%
Janney Montgomery Scott
180
Janney Montgomery Scott
Pennsylvania
$340K -$43.7K -3,258 -11%
VOYA Investment Management
181
VOYA Investment Management
Georgia
$325K -$11.1K -827 -3%
MM
182
MQS Management
New York
$325K +$351K +26,166 New
PA
183
Profund Advisors
Maryland
$323K +$34.7K +2,582 +11%
MSRPS
184
Maryland State Retirement & Pension System
Maryland
$310K +$335K +24,965 New
JF
185
Jump Financial
Illinois
$303K -$2.85M -212,025 -90%
AWP
186
Abacus Wealth Partners
California
$291K +$7.41K +552 +2%
M&T Bank
187
M&T Bank
New York
$289K -$3.64K -271 -1%
TI
188
Tidal Investments
Wisconsin
$284K +$71K +5,288 +30%
SCM
189
Sterling Capital Management
North Carolina
$281K -$170K -12,671 -36%
GAM
190
Gotham Asset Management
New York
$277K +$37.4K +2,785 +14%
AC
191
Allstate Corporation
Illinois
$269K +$290K +21,622 New
I
192
InceptionR
California
$261K +$282K +21,017 New
SLAM
193
Swiss Life Asset Management
$261K +$10.7K +794 +4%
HT
194
Headlands Technologies
Illinois
$255K -$554K -41,247 -67%
CFM
195
Catalyst Funds Management
Australia
$254K +$47K +3,500 +21%
Teacher Retirement System of Texas
196
Teacher Retirement System of Texas
Texas
$251K -$40.6K -3,022 -13%
Public Employees Retirement Association of Colorado
197
Public Employees Retirement Association of Colorado
Colorado
$246K – – –
MOACM
198
Mutual of America Capital Management
New York
$241K +$261K +19,427 New
XT
199
XTX Topco
Cayman Islands
$229K -$45.1K -3,362 -15%
Wealth Enhancement Advisory Services
200
Wealth Enhancement Advisory Services
Minnesota
$223K +$562K +41,872 +255%
6 7
8
9 10

AMRX Hedge Fund Activity: Q1 2026 in Review

315 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q1 2026, worth a combined $1.99B — up 2.1% from $1.95B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new AMRX positions and 36 closed out — a net gain of 43 holders — while 115 added to existing stakes and 78 trimmed.

The largest buyer was BlackRock, adding an estimated $137M. The largest seller was Citadel Advisors, cutting an estimated $75.2M.

  • 315 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q1 2026, up from 277 in Q4 2025.
  • Funds reported $1.99B of Amneal Pharmaceuticals stock for Q1 2026, up 2.1% quarter-over-quarter.
  • 79 funds opened new Amneal Pharmaceuticals positions in Q1 2026 and 36 closed out, a net change of +43 holders.
  • The largest Amneal Pharmaceuticals buyer in Q1 2026 was BlackRock, an estimated $137M added.
  • The largest Amneal Pharmaceuticals seller in Q1 2026 was Citadel Advisors, an estimated $75.2M sold.

Based on aggregated 13F filings for Q1 2026.